ESMO Preceptorship Gastroenteropancreatic Neuroendocrine Neoplasms Cancer Prague 2019

Start date: 12 Apr 2019
End date: 13 Apr 2019
Location: Prague, Czech Republic

Learning objectives

Familiarise with the epidemiology, classification and prognostication of Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NEN) patients
Introduce principles of diagnostic and therapeutic strategy and the role of a multidisciplinary team
Integrate different therapies in patients with advanced disease
Familiarise with the genetic aberrations and their evolving role in diagnosis and treatment
Update of new developments, clinical trials and unmet needs

Accreditation

The programme of this event will be accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Nicola Fazio, Italy
Gregory Kaltsas, Greece